Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole

Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arab journal of gastroenterology 2011-03, Vol.12 (1), p.44-47
Hauptverfasser: Hussein, Rola, El-Halabi, Mustapha, Ghaith, Ola, Jurdi, Nawaf, Azar, Cecilio, Mansour, Nabil, Sharara, Ala I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 1
container_start_page 44
container_title Arab journal of gastroenterology
container_volume 12
creator Hussein, Rola
El-Halabi, Mustapha
Ghaith, Ola
Jurdi, Nawaf
Azar, Cecilio
Mansour, Nabil
Sharara, Ala I.
description Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially – available combination of two antibiotics – spiramycin and metronidazole – commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.
doi_str_mv 10.1016/j.ajg.2010.11.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_858784489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1687197910001450</els_id><sourcerecordid>858784489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-cba3d02fc1ecdd2340429f986e8c3ebb1e9dc7409c467d7f3f4b08da8eca0ef3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwA1iQN6YUO0kTR0yo4kuqxEDFajnnC3WVxMF2CuXXk6qFkel00vO-unsIueRsyhnPbtZTtX6fxmy38ylj_IiMY1awKE5EfkzGPBN5xIu8GJEz79eMZRnn7JSMYp7GRTrLxuTtFTfokK6wU8EG-2XAhC1V3lswKqCmnyasaFghBduUplXB2JbaivrOONVswbS0q3tPGwzOtkarb1vjOTmpVO3x4jAnZPlwv5w_RYuXx-f53SKCOMtDBKVKNIsr4Ahax0nKhruqQmQoIMGy5FhoyFNWQJrlOq-SKi2Z0EogKIZVMiHX-9rO2Y8efZCN8YB1rVq0vZdiJnKRpqIYSL4nwVnvHVayc6ZRbis5kzuZci0HmXInU3IuB5lD5urQ3pcN6r_Er70BuN0DOLy4MeikB4MtoDYOIUhtzT_1Pzs1h7w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858784489</pqid></control><display><type>article</type><title>Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hussein, Rola ; El-Halabi, Mustapha ; Ghaith, Ola ; Jurdi, Nawaf ; Azar, Cecilio ; Mansour, Nabil ; Sharara, Ala I.</creator><creatorcontrib>Hussein, Rola ; El-Halabi, Mustapha ; Ghaith, Ola ; Jurdi, Nawaf ; Azar, Cecilio ; Mansour, Nabil ; Sharara, Ala I.</creatorcontrib><description>Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially – available combination of two antibiotics – spiramycin and metronidazole – commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.</description><identifier>ISSN: 1687-1979</identifier><identifier>EISSN: 2090-2387</identifier><identifier>DOI: 10.1016/j.ajg.2010.11.001</identifier><identifier>PMID: 21429456</identifier><language>eng</language><publisher>Egypt: Elsevier Ltd</publisher><subject>Adult ; Adverse events ; Anti-Bacterial Agents - adverse effects ; Antibiotics ; Antiprotozoal Agents - adverse effects ; Chemical and Drug Induced Liver Injury - diagnosis ; Chemical and Drug Induced Liver Injury - physiopathology ; Chemical and Drug Induced Liver Injury - therapy ; Drug ; Drug Combinations ; Humans ; Injury ; Liver ; Liver Transplantation ; Male ; Metronidazole - adverse effects ; Spiramycin - adverse effects ; Treatment Outcome</subject><ispartof>Arab journal of gastroenterology, 2011-03, Vol.12 (1), p.44-47</ispartof><rights>2010 Arab Journal of Gastroenterology</rights><rights>Copyright © 2010 Arab Journal of Gastroenterology. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c267t-cba3d02fc1ecdd2340429f986e8c3ebb1e9dc7409c467d7f3f4b08da8eca0ef3</citedby><cites>FETCH-LOGICAL-c267t-cba3d02fc1ecdd2340429f986e8c3ebb1e9dc7409c467d7f3f4b08da8eca0ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1687197910001450$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21429456$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hussein, Rola</creatorcontrib><creatorcontrib>El-Halabi, Mustapha</creatorcontrib><creatorcontrib>Ghaith, Ola</creatorcontrib><creatorcontrib>Jurdi, Nawaf</creatorcontrib><creatorcontrib>Azar, Cecilio</creatorcontrib><creatorcontrib>Mansour, Nabil</creatorcontrib><creatorcontrib>Sharara, Ala I.</creatorcontrib><title>Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole</title><title>Arab journal of gastroenterology</title><addtitle>Arab J Gastroenterol</addtitle><description>Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially – available combination of two antibiotics – spiramycin and metronidazole – commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.</description><subject>Adult</subject><subject>Adverse events</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Antibiotics</subject><subject>Antiprotozoal Agents - adverse effects</subject><subject>Chemical and Drug Induced Liver Injury - diagnosis</subject><subject>Chemical and Drug Induced Liver Injury - physiopathology</subject><subject>Chemical and Drug Induced Liver Injury - therapy</subject><subject>Drug</subject><subject>Drug Combinations</subject><subject>Humans</subject><subject>Injury</subject><subject>Liver</subject><subject>Liver Transplantation</subject><subject>Male</subject><subject>Metronidazole - adverse effects</subject><subject>Spiramycin - adverse effects</subject><subject>Treatment Outcome</subject><issn>1687-1979</issn><issn>2090-2387</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqXwA1iQN6YUO0kTR0yo4kuqxEDFajnnC3WVxMF2CuXXk6qFkel00vO-unsIueRsyhnPbtZTtX6fxmy38ylj_IiMY1awKE5EfkzGPBN5xIu8GJEz79eMZRnn7JSMYp7GRTrLxuTtFTfokK6wU8EG-2XAhC1V3lswKqCmnyasaFghBduUplXB2JbaivrOONVswbS0q3tPGwzOtkarb1vjOTmpVO3x4jAnZPlwv5w_RYuXx-f53SKCOMtDBKVKNIsr4Ahax0nKhruqQmQoIMGy5FhoyFNWQJrlOq-SKi2Z0EogKIZVMiHX-9rO2Y8efZCN8YB1rVq0vZdiJnKRpqIYSL4nwVnvHVayc6ZRbis5kzuZci0HmXInU3IuB5lD5urQ3pcN6r_Er70BuN0DOLy4MeikB4MtoDYOIUhtzT_1Pzs1h7w</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Hussein, Rola</creator><creator>El-Halabi, Mustapha</creator><creator>Ghaith, Ola</creator><creator>Jurdi, Nawaf</creator><creator>Azar, Cecilio</creator><creator>Mansour, Nabil</creator><creator>Sharara, Ala I.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole</title><author>Hussein, Rola ; El-Halabi, Mustapha ; Ghaith, Ola ; Jurdi, Nawaf ; Azar, Cecilio ; Mansour, Nabil ; Sharara, Ala I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-cba3d02fc1ecdd2340429f986e8c3ebb1e9dc7409c467d7f3f4b08da8eca0ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Adverse events</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Antibiotics</topic><topic>Antiprotozoal Agents - adverse effects</topic><topic>Chemical and Drug Induced Liver Injury - diagnosis</topic><topic>Chemical and Drug Induced Liver Injury - physiopathology</topic><topic>Chemical and Drug Induced Liver Injury - therapy</topic><topic>Drug</topic><topic>Drug Combinations</topic><topic>Humans</topic><topic>Injury</topic><topic>Liver</topic><topic>Liver Transplantation</topic><topic>Male</topic><topic>Metronidazole - adverse effects</topic><topic>Spiramycin - adverse effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussein, Rola</creatorcontrib><creatorcontrib>El-Halabi, Mustapha</creatorcontrib><creatorcontrib>Ghaith, Ola</creatorcontrib><creatorcontrib>Jurdi, Nawaf</creatorcontrib><creatorcontrib>Azar, Cecilio</creatorcontrib><creatorcontrib>Mansour, Nabil</creatorcontrib><creatorcontrib>Sharara, Ala I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arab journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussein, Rola</au><au>El-Halabi, Mustapha</au><au>Ghaith, Ola</au><au>Jurdi, Nawaf</au><au>Azar, Cecilio</au><au>Mansour, Nabil</au><au>Sharara, Ala I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole</atitle><jtitle>Arab journal of gastroenterology</jtitle><addtitle>Arab J Gastroenterol</addtitle><date>2011-03</date><risdate>2011</risdate><volume>12</volume><issue>1</issue><spage>44</spage><epage>47</epage><pages>44-47</pages><issn>1687-1979</issn><eissn>2090-2387</eissn><abstract>Drug-induced liver injury (DILI) is a leading cause of acute liver failure and is the most frequent reason for post-marketing drug withdrawal. The spectrum of liver injury is wide, ranging from mild and subclinical injury, noticeable only on routine biochemical testing, to fulminant liver failure and death. Antibiotics, as a group, are a leading cause of DILI. We herein describe 4 patients who developed moderate to severe hepatotoxicity after exposure to a commercially – available combination of two antibiotics – spiramycin and metronidazole – commonly used for the treatment and prevention of periodontal infections. No other aetiology for liver injury could be identified in all cases. Two patients recovered spontaneously, and two had a more severe course, one responding to corticosteroids and mycophenolate mofetil and the other requiring liver transplantation for subacute massive necrosis.</abstract><cop>Egypt</cop><pub>Elsevier Ltd</pub><pmid>21429456</pmid><doi>10.1016/j.ajg.2010.11.001</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1687-1979
ispartof Arab journal of gastroenterology, 2011-03, Vol.12 (1), p.44-47
issn 1687-1979
2090-2387
language eng
recordid cdi_proquest_miscellaneous_858784489
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Adverse events
Anti-Bacterial Agents - adverse effects
Antibiotics
Antiprotozoal Agents - adverse effects
Chemical and Drug Induced Liver Injury - diagnosis
Chemical and Drug Induced Liver Injury - physiopathology
Chemical and Drug Induced Liver Injury - therapy
Drug
Drug Combinations
Humans
Injury
Liver
Liver Transplantation
Male
Metronidazole - adverse effects
Spiramycin - adverse effects
Treatment Outcome
title Severe hepatotoxicity associated with the combination of spiramycin plus metronidazole
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20hepatotoxicity%20associated%20with%20the%20combination%20of%20spiramycin%20plus%20metronidazole&rft.jtitle=Arab%20journal%20of%20gastroenterology&rft.au=Hussein,%20Rola&rft.date=2011-03&rft.volume=12&rft.issue=1&rft.spage=44&rft.epage=47&rft.pages=44-47&rft.issn=1687-1979&rft.eissn=2090-2387&rft_id=info:doi/10.1016/j.ajg.2010.11.001&rft_dat=%3Cproquest_cross%3E858784489%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=858784489&rft_id=info:pmid/21429456&rft_els_id=S1687197910001450&rfr_iscdi=true